Thomas Richardson Partners — Where Healthcare Strategy Becomes Actual Performance
Thomas Richardson Partners is a transatlantic healthcare advisory working at the intersection of investor ambition and operational reality. With deep operator experience across both the UK and US, we help private equity and strategic investors unlock the value trapped inside healthcare assets. At Thomas Richardson Partners our senior advisors convert strategy into performance within some of the world’s most complex health systems.
Today’s Challenge
Healthcare investments rarely fail because the strategy was wrong. They underperform because executional assumptions were never interrogated with real operator insight. Structural friction—regulatory constraints, policy misalignment, workflow gaps and legacy infrastructure—suppresses performance on both sides of the Atlantic. Investors quickly discover that identifying the right asset is only the first step; translating the thesis into real‑world performance is the true challenge.
More than a trillion dollars has been invested in private healthcare over the past decade, yet exit activity remains flat and value capture remains elusive. The constraint is not demand but the chronic underestimation of executional complexity embedded across UK and US healthcare systems.
A New Solution
Thomas Richardson Partners introduces a model built specifically for the realities of healthcare delivery. Senior‑led, execution‑focused and shaped by decades of operator experience in both the UK and the US, we bridge investor logic with the lived reality of clinical and operational delivery. We create clarity quickly and unlock traction where friction has historically eroded returns.

The approach is intentionally boutique: discreet, analytically disciplined and deeply grounded in the operational, regulatory and cultural nuances unique to each side of the Atlantic.
Our Focus
We specialise in diagnosing and resolving the structural and operational barriers that routinely derail healthcare value creation. Across UK and US markets, conflicting incentives, policy contradictions and outdated infrastructure restrict scaling, while commercialisation gaps slow adoption despite strong innovation. Integration and workflow optimisation remain consistently underestimated challenges across transatlantic care delivery.
These patterns are not random. They repeat across healthcare M&A, and our firm has the operating depth to anticipate and resolve them rapidly.
How We Support the Investment Lifecycle
Before LOI, we test operational reality and execution viability to ensure the thesis can withstand the friction inherent to UK and US healthcare environments. As deals approach close, we validate integration feasibility and align 100‑day expectations with system constraints. After close, we embed momentum, align regulatory and workflow pathways and ensure early traction. As the asset matures, we identify early drift and correct performance before it erodes long‑term value.

The work is not conceptual. It is grounded in deep operational leadership and executed with the precision expected by private equity and strategic investors.
Our Founders

Phil Richardson, Principal
A senior health strategist with extensive experience driving service transformation, innovation and system‑level change across both UK and US systems. Philip specialises in translating complex operational, clinical and regulatory constraints into actionable investment and operational decisions.

Anna Thomas, Principal
With more than fifteen years of experience in healthcare transformation and change‑enablement consulting, Anna brings deep experience in integration, operating model redesign and large‑scale implementation across transatlantic systems.
Together, they bring more than forty years of combined operator‑side expertise. Their work is grounded in practical delivery, not theoretical consulting.
Start a Conversation
If you want to turn a strong healthcare strategy into predictable, repeatable and scalable performance across UK and US systems, we would welcome a conversation. Thomas Richardson Partners brings the clarity, pace and operational credibility required to succeed in the world’s most complex health markets.
